ProfoundBio, a Seattle-based biotech firm developing drugs to treat ovarian and endometrial cancers, will be acquired by publicly traded Danish drugmaker Genmab in a $1.8 billion all-cash deal expected to… Read More
The news: Modulus Therapeutics, a Seattle-based cellular therapy company spun out of the Allen Institute of Artificial Intelligence (AI2) Incubator, has sold its cell therapy platform assets to the Boston… Read More
Researchers opened the doors Monday to the new Seattle Hub for Synthetic Biology, a collaboration between the Allen Institute, the Chan Zuckerberg Initiative and the University of Washington. The hub combines “academic creativity with… Read More
Sonoma Biotherapeutics on Monday hosted a ribbon cutting ceremony at its new research and development center and office space on Seattle’s waterfront. The biotech company, which has a second location… Read More
A good idea, preliminary data, and credentials in the field are all key components of landing a small business grant from the U.S. government to launch or expand a company.… Read More
More than 100 researchers — including a Nobel laureate — have signed on to a call for the scientific community to follow a set of safety and security standards when… Read More
Seattle biotech startup Phase Genomics is receiving $1.5 million from the Bill & Melinda Gates Foundation to fund research into two important areas: killing drug-resistant bacteria and battling methane-producing microorganisms… Read More
The Institute for Protein Design at the University of Washington is a startup factory, spinning out companies developing new protein-based therapeutics, industrial enzymes, materials, biosensors and more. A key to… Read More
A team working on prolonging the lifespan of transplant organs took home the top prize in the 9th annual Hollomon Health Innovation Challenge at the University of Washington. BioLegacy, made up of… Read More
PATH, the global health nonprofit, is moving to a new headquarters space in Seattle’s Fremont neighborhood after 15 years in South Lake Union. PATH announced a lease agreement Thursday with… Read More
Healionics, a Seattle-based medical technology company, raised $5.5 million in new financing aimed at helping the company complete an ongoing human trial and pursue regulatory clearance and commercialization of its… Read More
Biotech giant AstraZeneca has completed its $1.1 billion acquisition of Icosavax, a Seattle-based spinout from the University of Washington’s Institute for Protein Design.
ProfoundBio raised $112 million to support development of its pipeline of antibody-drug conjugates (ADCs), agents that recognize a molecular target via an antibody and deliver a toxin or other compound to… Read More
Just in time for new year’s resolutions, the Fred Hutchinson Cancer Center is releasing a free app that employs an artificial intelligence-powered chatbot to help people stop smoking. Through an… Read More
The halls at a recent meeting of biologists in Seattle were buzzing with more than just the usual excitement about spiders, bats, bees, elephants and other creatures. Researchers were also… Read More
A new Seattle-based startup called Avante confirmed that it raised $10 million in a seed funding round led by Fuse Venture Partners, saying it’s building a company with ambitions to… Read More
Yuzi founder Stephiney Foley graduated from West Point and worked for the U.S. Army for more than seven years, serving as a platoon leader in Afghanistan and Hawaii and a… Read More
Editor’s note: William Canestaro is managing director at Seattle venture capital firm WRF Capital and leads the biotechnology investment team. Seagen’s sale to Pfizer would have seemed unthinkable a few… Read More
Prenuvo, the celebrity-endorsed company offering $2,500 full-body MRI scans designed to detect cancer and other diseases early, is planning to open one of its clinics in Seattle in 2024. Silicon… Read More
Neuroscientists have unveiled their most comprehensive and detailed map of cell types across the entire mouse brain, delivering the latest results of a six-year-long scientific effort in which Seattle’s Allen… Read More
Pfizer’s plan to acquire Seagen for $43 billion has cleared the necessary regulatory hurdles, the pharma titan announced Tuesday. The deal will close on Thursday. Seagen is the largest biotech… Read More
Seattle-based Icosavax, a spin-out from the University of Washington’s Institute for Protein Design, will be acquired by biotech giant AstraZeneca for up to $1.1 billion. The pending acquisition, announced Tuesday, values… Read More
The Allen Institute, the Chan Zuckerberg Initiative and the University of Washington have launched a collaboration called the Seattle Hub for Synthetic Biology, with the goal of using genetically modified… Read More
Valant Medical Solutions, a Seattle startup that develops software to help behavioral health practitioners manage billing and electronic medical records at their offices, has been sold to Resurgens Technology Partners, a private… Read More
Some of the biggest names in longevity research — and at least one Seattle biotech startup — say they’ll enter a $101 million, seven-year competition to turn back the clock… Read More
Shares of Seattle-based publicly traded biotech company NanoString Technologies fell nearly 50% to an all-time low on Monday following its loss in a patent infringement case against 10x Genomics. A… Read More
With revenues declining and net losses increasing, Seattle-based Adaptive Biotechnologies on Thursday said it hired Goldman Sachs to help conduct a review of strategic alternatives for its Minimal Residual Disease… Read More
The Paul G. Allen Frontiers Group, a division of the Seattle-based Allen Institute, is launching a research center in New York to focus on interactions between the nervous system and… Read More
AdaptX, a Seattle tech company that uses AI to help healthcare providers analyze medical data to improve patient care, raised an additional $10 million to support its growth and further… Read More
A group of 20 early-stage life sciences startups in Washington each received $25,000 grants, part of an effort to fuel the “next generation” of life science innovation in the state.… Read More
